The DURABLE project better prepares Europe for the next pandemic. The new consortium includes virological and epidemiological research laboratories and will receive 25 million euros from the EU. Head of Virology at Erasmus MC Marion Koopmans is co-coordinator: ‘The next pandemic is possibly at our doorstep.’
Infection & Immunity
A widely used anti-parasite drug awakens the virus from a dormant state in people living with HIV. This was discovered by scientists at Erasmus MC in the first study to test this drug in people living with HIV. ‘The road to cure is still long.’
AstraZeneca’s adenovirus-based covid-19 vaccine is associated with a 30 percent increased risk of the rare side effect thrombocytopenia, or too few platelets, compared to Pfizer’s mRNA covid-19 vaccine. This has been confirmed by research coordinated by Erasmus MC’s Department of Medical Informatics, published in The BMJ.
The best way to address risk factors for future pandemics is a One Health approach that balances and optimizes the health of people, animals, and ecosystems. That is the message of the The Independent Task Force on COVID-19 and other Pandemics, which includes Prof Dr Marion Koopmans of the Erasmus MC and Pandemic & Disaster […]
The omicron BA.1 variant of SARS-CoV-2 is less infectious in the brain and triggers less inflammation in brain cells than the virus variant responsible for the first SARS-CoV-2 wave. This has been shown in research with hamsters and human brain cells by scientists from the Erasmus MC. ‘Good news, but no guarantees for the future.’
A patient with an immune disorder and neurological problems brought together an international team of scientists and clinicians from Rotterdam and Vienna. Together they determined that all his symptoms have the same genetic cause.
A study of more than eight million vaccinated people finds no increased risk of rare neurological events after covid-19 vaccination. An increased risk was, however, seen after SARS-CoV-2 infection.